We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
What 'single-use' means and what symbol is used by manufacturers to show this.
This publication supports local authority health and wellbeing boards to develop and update pharmaceutical needs assessments (PNAs).
The MHRA has published advice for patients and healthcare professionals
Sets out the payment due from members of the voluntary scheme for branded medicines pricing, access and growth in 2025.
Supplementary information on the licensing of medicines for human use in the UK following the agreement of the Windsor Framework.
How to use RamaXL, including system availability, running reports and how to subscribe.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
How manufacturers can comply with the regulations when providing instructions for using medical devices in an electronic form.
Types of ingredients permitted in nicotine-containing liquids in electronic cigarettes and refill containers.
How to carry out the biological safety evaluation, which is required before undertaking a clinical investigation for a medical device.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Guidance for industry on flexible approaches we are taking on good distribution practices.
Actions that trial sponsors should consider to build resilience into clinical trial design
Clinical trials Route B substantial modifications pilot starts on 1 October 2025. Prepare for the implementation of new regulations from 28 April 2026.
A user guide for understanding and applying the national taxonomy for incident learning in clinical imaging, magnetic resonance imaging and nuclear medicine.
Report on the public health impact of nurses and midwives, dentists, allied health professionals and pharmacists.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
A 5-year voluntary scheme on the control of prices agreed between government and the Association of the British Pharmaceutical Industry (ABPI).
Guidelines for communicating clear and relevant information about machine learning-enabled medical devices.
Guidance on the updates to reporting forms following implementation of the Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).